Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cortexyme
company
About
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $76M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$99M
Cortexyme has raised a total of
$99M
in funding over 2 rounds. Their latest funding was raised on
May 31, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2018 | Series B | $76M | 3 |
Sequoia Capital
|
— | Detail |
| Apr 14, 2017 | Debt Financing | $8M | 2 | — | — | Detail |
| Jan 6, 2016 | Series A | $15M | 1 |
Pfizer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Cortexyme is funded by 4 investors.
Sequoia Capital
and Verily
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
Yes | Series B |
Verily
|
— | Series B |
|
|
— | Series B |
|
Pfizer
|
— | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
